Dasafav 100 mg Tablet
  1. Home
  2. Pharma Products
  3. Aureate Healthcare Pvt Ltd
  4. Dasafav 100 mg Tablet

Dasafav 100 mg Tablet

Dasafav 100 mg Tablet contains dasatinib, an oral anticancer medicine used for certain types of leukemia. It is used mainly for Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. Dasatinib works by blocking abnormal tyrosine kinase proteins that support leukemia cell growth.

BUY NOW

Category

Dasafav 100 mg Tablet is a tyrosine kinase inhibitor prescribed for eligible patients with specific forms of Philadelphia chromosome-positive leukemia. Dasatinib inhibits BCR-ABL and other kinase proteins involved in the growth and survival of abnormal blood cells. It may be used in chronic, accelerated, or blast phases of CML depending on the patient’s treatment history and clinical condition. Treatment requires specialist supervision with regular monitoring of blood counts, treatment response, and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 100 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer/Marketer Aureate Healthcare Pvt Ltd

Product Also Known As

Dasafav 100 mg Tablet, Dasatinib 100 mg Tablet, Dasafav Dasatinib Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet, Tyrosine Kinase Inhibitor Tablet